• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Achieve Life Sciences, Inc. - Common Shares (NQ:ACHV)

    5.280 -0.210 (-3.83%)
    Streaming Delayed Price Updated: 2:28 PM EST, Jan 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Achieve Life Sciences, Inc. - Common Shares

    < Previous 1 2 Next >
    News headline image
    Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Life Science Investor Forum: Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
    Topline Data Expected in 2Q 2023 
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Life Science Investor Forum Agenda Announced for December 14th, 2023
    From Virtual Investor Conferences
    Via GlobeNewswire
    Achieve Life Sciences Inc. (NASDAQ: ACHV) Climbs to New 52-Week High
    Via Investor Brand Network
    News headline image
    Achieve Life Sciences Announces Refresh to Board of Directors
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
    Topline Data Expected in 2Q 2023 
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
    Topline Data Expected in 2Q 2023 
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences Announces Granting of New Hire Inducement Award
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences Announces Granting of New Hire Inducement Award
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences Announces Private Placement of $18.9 Million
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial
    Phase 2 ORCA-V1 Data Expected in 1H2023 
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022
    From Achieve Life Sciences
    Via GlobeNewswire
    News headline image
    36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
    RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public... 
    From MicroCap Rodeo
    Via AccessWire
    News headline image
    36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
    RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public... 
    From MicroCap Rodeo
    Via AccessWire
    News headline image
    Achieve Life Sciences to Participate in Upcoming Investor Conferences
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / September 15, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and... 
    From Achieve Life Sciences, Inc.
    Via AccessWire
    Topics Death
    News headline image
    Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 21st Annual Society for Research on Nicotine & Tobacco (SRNT-E) Virtual Conference
    SEATTLE, WA & VANCOUVER, BC / ACCESSWIRE / September 14, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and... 
    From Achieve Life Sciences, Inc.
    Via AccessWire
    Topics Death Intellectual Property
    News headline image
    Achieve Life Sciences to Participate in Two Upcoming Investor Conferences
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / September 9, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and... 
    From Achieve Life Sciences, Inc.
    Via AccessWire
    Topics Death
    News headline image
    Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Awards
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 13, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and... 
    From Achieve Life Sciences, Inc.
    Via AccessWire
    Topics Death Intellectual Property
    News headline image
    Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and... 
    From Achieve Life Sciences, Inc.
    Via AccessWire
    Topics Death Intellectual Property
    News headline image
    Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing and Administration Regimen
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 11, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and... 
    From Achieve Life Sciences, Inc.
    Via AccessWire
    Topics Death Intellectual Property
    News headline image
    Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 3, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and... 
    From Achieve Life Sciences, Inc.
    Via AccessWire
    News headline image
    Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 22, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization... 
    From Achieve Life Sciences, Inc.
    Via AccessWire
    Topics Death Intellectual Property
    News headline image
    Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline
    ORCA-2 Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo in Adult Smokers in the United States SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE /... 
    From Achieve Life Sciences, Inc.
    Via AccessWire
    Topics Death Intellectual Property
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.